A clinic buys a rapid-readout biological indicator because the number on the box answers a scheduling problem: a load sterilized at nine in the morning can be released before the last patient of the day. The number is real, but it is the smallest part of what a regulator actually cleared. Behind every "20 minutes" or "1 hour" sits a premarket file that names the cycles the claim covers, the reader software version the claim depends on, the sterilization modality it was tested against, and the product code the device was filed under. Read that file and the claim shrinks to its true size. Skip it and the number becomes a belief about release practice that no document supports.
This article reads six recent United States clearance documents for biological indicators — from a 20-second visual device cleared in 2026 back to a 24-hour vial cleared in 2019 — and then asks the question the clearance cannot answer: which Canadian licence applies to the same product, and which one does not. A clinic that stocks the 20-minute fluorescence indicator and the four-well fluorescence reader is buying a monitoring instrument, not a release policy, and the distinction is where inspection findings are born.


What does a 510(k) clearance for a biological indicator actually state?
A clearance letter is short and repetitive, and four fields carry the operational weight. The first is the regulation number and class: the Attest 1492V clearance K241710 names 21 CFR 880.2800(a), "Biological Sterilization Process Indicator", Class II, product code FRC. The second is the indications for use, which is where the readout time lives — not in the marketing name. The third is the accessory list, because a fluorescence result is produced by the reader, not the vial, so the reader model and its software version are part of the cleared claim. The fourth is the cycle table: the clearance states the exposure temperatures and times the indicator was tested against, and a cycle outside that table is outside the claim.
K241710 illustrates all four. The indications for use attach the 1492V to the Attest Auto-reader 490, 490H and Mini 490M; the summary states a final fluorescent result at 24 minutes in the 490 and 490H "having software version 4" and in the 490M, a one-hour final fluorescent result in 490 readers with software versions below 4, and an optional visual pH colour change result at 48 hours. The claimed cycles are dynamic-air-removal steam at 132 °C for 3 or 4 minutes, 134 °C for 3 or 4 minutes, and 135 °C for 3, 3.5 or 10 minutes. Nothing in that document says how long a clinic may hold a load before release. It says what the device was shown to do inside those cycles, on those readers.
How short has the readout actually been cleared, and by what evidence?
The table below lists only claims that can be read in the clearance document itself. That restriction matters: product names are unreliable guides to readout time. The Terragene Bionova BT20, cleared under K251122 in 2025, carries a "20" in its name and states a final result after a 24-hour incubation at 60 °C. A clinic that ordered it expecting a 20-minute readout would have bought the wrong instrument for its workflow and would only discover it at the incubator.
| Clearance (date) | Device | Claimed readout | Modality | Product code |
|---|---|---|---|---|
| K251559 (2026-06-18) | InstaTRU Instant BI for Steam, IBI-05 | Visual confirmation in 20 seconds, no incubation | Steam, gravity and dynamic-air-removal | QVB |
| K192025 (2020-01-23) | STERRAD VELOCITY Biological Indicator / PCD and reader | Final fluorescence in 15 minutes at 57 ± 2 °C | Vaporized hydrogen peroxide | FRC |
| K181686 (2018-07-24) | Celerity 20 Steam Biological Indicator | Fluorescent result within 20 minutes | Steam | FRC |
| K241710 (2024-09-12) | Attest 1492V with 490 / 490H at software version 4, or 490M | Final fluorescent result at 24 minutes | Steam, dynamic-air-removal | FRC |
| K241710 (2024-09-12) | Attest 1492V with 490 at older software | Final fluorescent result at 1 hour; optional visual pH result at 48 hours | Steam, dynamic-air-removal | FRC |
| K183300 (2019-01-03) | VERIFY V24 self-contained biological indicator | Incubation at 55–60 °C for at least 24 hours | Vaporized hydrogen peroxide | FRC |
| K251122 (2025-08-04) | Terragene Bionova BT20 | Final result after 24-hour incubation at 60 ± 2 °C | Steam | FRC |
| ISO 11138-1:2017, 7.3.2 | Reference incubation time | 7 days | Moist heat and ethylene oxide | — |
Two patterns fall out of the table. Readout length is tied to modality, not to vendor ambition: the shortest claims sit on steam and on vaporized hydrogen peroxide where the chemistry is fastest, and the same manufacturer sells a 24-hour vial beside a 24-minute one. And the shortest claim of all, 20 seconds, was cleared in 2026 under a different product code — QVB, mapped to 21 CFR 880.2806, "Biological Sterilization Indicator With Indirect Growth Detection" — rather than the FRC code that covers the older family. A new code is a signal that the review pathway changed, and a clinic reading a specification sheet should notice which code its supplier is describing.
What has to be demonstrated before a readout shorter than seven days is allowed?
The reference point is not a marketing decision. ISO 11138-1:2017 sets a seven-day reference incubation time in 7.3.2, and ISO 11138-8:2021 exists precisely to test a shorter one: its scope describes a method "to establish or confirm a reduced incubation time (RIT) that is shorter than the 7-day reference incubation time specified in 7.3.2 of ISO 11138-1:2017", for biological indicators used to monitor moist heat or ethylene oxide sterilization. The note in that scope adds a boundary that clinics rarely hear: for ethylene oxide indicators the stated RIT applies to 100 percent EO processes or processes using EO blends, so a claim does not automatically travel between the two.
The performance work behind a shorter readout is not one test but a set. In K241710 the sponsor reports, across three lots, positive control, D-value, survival and kill testing for the 134 °C cycles, a reduced incubation time study, a holding-time assessment, and simulated use testing in the claimed cycles; the kill-time calculation is footnoted to ISO 11138-1:2017 Annex E. The submission also names the FDA guidance it followed, the 2007 document on biological indicator premarket notification submissions. What a clinic can take from this is narrow but useful: a shorter readout is a demonstrated property of a specific spore preparation, carrier and medium, read on a specific instrument, inside specific cycles. Change any of those and the demonstration has to be repeated by whoever changes it.
Where does a cleared claim stop?
The 2026 clearance for the InstaTRU IBI-05 draws the line in the indications for use itself. The device provides "visual confirmation in 20 seconds" and requires no incubation, and the same paragraph says it "is not recommended and should not be used for qualification testing purposes". That sentence is the clearest statement in the recent record of what a fast readout is for: routine monitoring of loads, not qualification of a sterilizer, not validation of a cycle, not the evidence a clinic would want to produce if a sterilizer's performance were in question.
Three further boundaries apply to every product in the table. First, the claim is cycle-specific: a 24-minute result demonstrated at 132, 134 and 135 °C in dynamic-air-removal cycles does not describe a 121 °C gravity cycle. Second, it is reader-specific: a fluorescent readout depends on an instrument and a software version, and mixing vials with a different reader is not a smaller version of the cleared use. Third, it is a monitoring claim, not a sterility claim: a negative indicator is evidence that the process delivered the lethality conditions the indicator was built to detect, and the packaging, the load configuration and the drying stage remain separate questions with separate standards.
| Document | What it establishes | What it does not establish | Who it binds |
|---|---|---|---|
| 510(k) clearance letter and summary | The device may be marketed in the United States for the stated indications, cycles and accessories | Any release, holding or record rule in a clinic | The manufacturer, in the US market |
| Manufacturer instructions for use | Intended use, storage, activation, incubation temperature and readout time for that catalogue number | That the clinic's sterilizer delivers the cycle the claim was tested in | The user, as labelled use |
| ISO 11138-1:2017 and ISO 11138-8:2021 | Performance requirements for indicators generally, and the method for a reduced incubation time | That a given clinic's cycle matches the tested conditions | Manufacturers and test laboratories |
| Provincial infection control standard | How often monitoring is done, and what is recorded | How long a load must be held before release, which is set by facility procedure | The dental office or facility |
| Facility written procedure | The release rule staff actually follow, including implant loads | Anything about the indicator's performance | Staff, and the inspector reading the record |
Does a faster readout shorten the hold time before release?
No. This is the sentence that separates a well-run clinic from a clinic with a good indicator. A readout time is how long the indicator takes to report. A hold time is a facility decision about how long a load waits before it is used, and it is written in the clinic's procedure and, for some load types, fixed by a provincial standard. Shortening the readout makes a shorter hold time possible; it does not create the permission, and no clearance document confers it.
Ontario dental practice is the clearest example because the monitoring obligation is daily, not weekly. The RCDSO standard of practice expects a biological indicator for each sterilizer on each day it is used, and for each type of cycle used, placed in a process challenge device. Manitoba's guidance for dental offices states the same interval in the same words — monitoring for each sterilizer and each cycle at least once daily that the sterilizer is used. Pages that quote a weekly frequency for Ontario are repeating an American baseline: the interval in United States guidance and in ANSI/AAMI ST79 is weekly, and it is useful for comparison, not as an Ontario or Canadian requirement. A clinic that buys a 24-minute indicator and then cites a weekly schedule has bought speed and applied it to the wrong clock.
Implant loads are the other place where speed is easily misread as permission. Where a clinic's procedure requires the biological result before an implant load is released, a 24-minute readout makes same-day release practical; it does not delete the hold. The record still has to show the load, the indicator, the incubation start, the result and the release decision, because the question an inspector asks is not how fast the vial read but whether the load was held until the answer existed.
How does Canada regulate the same product and the same claim?
A United States clearance has no legal effect in Canada. What applies here is the Medical Devices Regulations, SOR/98-282, and it asks two different questions that clinics routinely collapse into one. The first is whether the device needs a licence: section 26 prohibits importing or selling a Class II, III or IV device unless the manufacturer holds a licence for it. The second is whether the establishment needs a licence: subsection 44(1) prohibits importing or selling any medical device unless the person holds an establishment licence, with exemptions in 44(2) for retailers, health care facilities and manufacturers in the circumstances set out there. A Class I device therefore needs no device licence and still moves through licensed establishments.
Which of those two applies to a biological indicator depends on classification, and the classification rules are where the answer is decided rather than assumed. Schedule 1, Rule 7(1) puts most non-invasive devices in Class I; Rule 7(2) moves a non-invasive device to Class II when it is intended "to act as a calibrator, tester or quality control support to another medical device", or to be connected to an active device that is Class II, III or IV. An indicator whose whole purpose is to test whether a sterilizer did its job sits close to that language, which is why the classification of a specific product should be read off the licence record rather than argued from the product's shape. Those records are published in the Medical Devices Active Licence Listing (MDALL). A buyer can look up a model there before putting any question to a supplier.
The practical consequence for procurement is simple and uncomfortable. Asking a Canadian supplier "is this FDA cleared?" answers a United States question. The Canadian questions are: which class is this device, does the manufacturer hold a device licence if the class requires one, and does the establishment importing or distributing it hold an establishment licence. CliniEco Medical distributes under MDEL #35334; that number describes an establishment licence, and it is not a statement that any particular indicator carries a device licence of its own.
What should a clinic record so that the claim can be checked later?
The record that survives an inspection is short, but it has to be specific enough that someone else could reconstruct the decision. The fields below are the ones that turn a fast readout into evidence rather than an anecdote.
| Record field | Why it matters when the claim is questioned |
|---|---|
| Sterilizer identifier and cycle type | Places the load inside, or outside, the cycle table the indicator was cleared against |
| Indicator catalogue number and lot | Identifies which readout claim applies — the same brand sells 24-minute and 24-hour formats |
| Reader model and software version | A fluorescent readout time is tied to the instrument that produced it |
| Activation time and incubation start | Shows the readout interval was actually elapsed before the result was recorded |
| Result and time read | The evidence that the load was held until the answer existed |
| Release decision and who made it | Separates the monitoring result from the facility's release rule, which are different documents |
None of this is exotic, and none of it requires a new form. It requires the clinic to stop treating the readout number as the whole claim. The number is the end of a chain that runs from a spore preparation, through a validated reduced incubation time, through a reader and a cycle table, into a facility procedure that decides when a load may be used. Each link has a document behind it. A clinic that can name all five can defend the load; a clinic that can name only the number is defending a hope.
Where does a clinic take this next?
Three things a clinic can act on rather than read: a printable compliance log sheet that records dates, lot numbers and results and exports from the browser; the clinic supply planner that turns daily bench counts into cases per month; and, where a finding has to be documented for an inspector, Ask your compliance question which returns a written answer citing the regulation or standard it rests on.
Facility and multi-site buyers can Wholesale and multi-site ordering for case pricing and account setup. Reselling? become a distributor.
Related reading
- 20-minute biological indicators: where they fit in Canadian practice
- A 24-hour biological indicator reads tomorrow: what should be written today
- What must a clinic record for each biological indicator cycle?
- What ISO 11138 requires of a rapid readout
Is a cleared 20-minute readout a licence to release a load in 20 minutes?
No. The clearance describes how long the indicator takes to report, not how long a load may be held. The hold time comes from the facility's written procedure and, for some load types, from the provincial standard that applies to the practice. Readout time makes a shorter hold possible; it does not authorise one.
Does a United States 510(k) clearance permit sale in Canada?
No. A 510(k) clearance is a United States premarket notification and has no standing under the Medical Devices Regulations. In Canada the questions are whether the device's class requires a device licence held by the manufacturer, under section 26, and whether the establishment importing or distributing it holds an establishment licence, under subsection 44(1).
Are biological indicators Class I or Class II in Canada?
That depends on the device and must be read off its licence record rather than inferred. Schedule 1, Rule 7(1) places most non-invasive devices in Class I, while Rule 7(2) moves a non-invasive device to Class II when it is intended to act as a calibrator, tester or quality control support to another medical device. The Medical Devices Active Licence Listing is where a specific model can be checked.
Why does the same manufacturer sell both 24-minute and 24-hour indicators?
Because the readout is a property of the spore preparation, the medium and the reading instrument, and the shortest formats need a reader. A fluorescence vial read at 24 minutes and a self-contained vial read by colour change at 24 hours answer different workflow problems, and the clearance file for each states its own cycles and accessories.
What does ISO 11138-8:2021 add that ISO 11138-1:2017 does not?
ISO 11138-1:2017 sets a seven-day reference incubation time in 7.3.2 and the general performance requirements. ISO 11138-8:2021 supplies the method used to establish or confirm a reduced incubation time shorter than that reference, for moist heat and ethylene oxide indicators, including the boundary that the stated time applies to the ethylene oxide process type it was tested in.
Do we still need a daily indicator if we use a rapid-readout product?
Yes. In Ontario the RCDSO standard expects a biological indicator for each sterilizer on each day it is used and for each cycle type used, placed in a process challenge device. A faster readout changes when the answer arrives, not how often the test is run. The weekly frequency quoted in some summaries is a United States baseline, valuable for comparison and not an Ontario requirement.
Sources
- FDA 510(k) K241710, 3M Attest 1492V with Auto-readers 490, 490H and 490M — accessdata.fda.gov - FDA 510(k) K251559, InstaTRU Instant Biological Indicator for Steam IBI-05 — accessdata.fda.gov - FDA 510(k) K181686, Celerity 20 Steam Biological Indicator — accessdata.fda.gov - FDA 510(k) K252680, Celerity 20 HP Biological Indicator — accessdata.fda.gov - FDA 510(k) K192025, STERRAD VELOCITY Biological Indicator and reader — accessdata.fda.gov - FDA 510(k) K183300, VERIFY V24 Self-Contained Biological Indicator — accessdata.fda.gov - FDA 510(k) K251122, Terragene Bionova BT20 — accessdata.fda.gov - FDA product classification, FRC and QVB — accessdata.fda.gov - 21 CFR 880.2800, Sterilization process indicator, Class II (performance standards) — govinfo.gov - ISO 11138-1:2017, Sterilization of health care products — Biological indicators — General requirements — evs.ee - ISO 11138-3:2017, Biological indicators for moist heat sterilization processes — evs.ee - ISO 11138-8:2021, Method for validation of a reduced incubation time — evs.ee - ISO 17665:2024, Moist heat sterilization processes (replaces ISO 17665-1:2006) — evs.ee - Medical Devices Regulations, SOR/98-282, sections 26 and 44 and Schedule 1 — laws-lois.justice.gc.ca - RCDSO, standards and guidelines on infection prevention and control — rcdso.org - College of Dental Hygienists of Manitoba, infection prevention and control guidebook — cdhm.info - Health Canada, Medical Devices Active Licence Listing (MDALL) — health-products.canada.caCliniEco Medical distributes clinic and laboratory consumables in Canada under MDEL #35334. Requirements that bind a specific clinic or laboratory remain the ones in its own licence, its quality programme and its written procedure.
Last updated: 12 November 2026.